Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Colorectal cancer (CRC) is the second most common cancer in Malaysia. Diagnosing CRC at early stage is crucial to reduce their mortality risk. To achieve this aim, CRC screening promotion intervention is deemed necessary.
High-quality CRC screening interventions and approaches should be delivered to a large proportion of target population.
To our knowledge, there is no interactive video been developed, that can be used as educational tool for CRC screening in Malaysia. By developing an educational video, we hope that it can be used by health professionals to promote CRC screening, favoring their empowerment for prevention and control of disease.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Intervention | Experimental | Participants will receive decision-aid video |
|
| Usual care | No Intervention | Participants will receive usual care |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Decision-aid video | Other | Decision-aid video will be developed to disseminate knowledge and to raise awareness on colorectal cancer screening |
|
| Measure | Description | Time Frame |
|---|---|---|
| Number of participants with colorectal cancer screening completion | Number of participants with completion of fecal occult blood test or colonoscopy procedures by participants | 3 months |
| Measure | Description | Time Frame |
|---|---|---|
| Number of participants with colonoscopy completion among those with positive fecal occult blood test | Number of participants who are completed colonoscopy among those positive fecal occult blood test | 3 months |
| Period time from intervention to fecal occult blood test uptake |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Azmawati Mohammed Nawi, Medical | Contact | +6 03 8921 5555340 | azmawati@ppukm.ukm.edu.my |
| Name | Affiliation | Role |
|---|---|---|
| Azmawati Mohammed Nawi | The National University of Malaysia | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| The National University of Malaysia | Cheras | Kuala Lumpur | 56000 | Malaysia |
Only three principal investigators will have access to participants' data
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D015179 | Colorectal Neoplasms |
| ID | Term |
|---|---|
| D007414 | Intestinal Neoplasms |
| D005770 | Gastrointestinal Neoplasms |
| D004067 | Digestive System Neoplasms |
| D009371 | Neoplasms by Site |
Not provided
Not provided
Parallel randomized controlled trial will be conducted in 3 months duration, with intention-to-treat.
Not provided
Not provided
Investigators will designate participants to which arm using random sampling. Participants and care providers are masked to which arm they receive.
Duration taken after received intervention to screening uptake |
| 3 months |
| Barriers towards the colorectal cancer screening uptake | List of barriers (numbers) towards the colorectal cancer screening uptake | 3 months |
| D009369 | Neoplasms |
| D004066 | Digestive System Diseases |
| D005767 | Gastrointestinal Diseases |
| D003108 | Colonic Diseases |
| D007410 | Intestinal Diseases |
| D012002 | Rectal Diseases |